Evan F. Williams

441 total citations
23 papers, 342 citations indexed

About

Evan F. Williams is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Evan F. Williams has authored 23 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Physiology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Evan F. Williams's work include Adenosine and Purinergic Signaling (9 papers), Lanthanide and Transition Metal Complexes (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). Evan F. Williams is often cited by papers focused on Adenosine and Purinergic Signaling (9 papers), Lanthanide and Transition Metal Complexes (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). Evan F. Williams collaborates with scholars based in United States, Canada and Belarus. Evan F. Williams's co-authors include Phil Skolnick, Steven M. Paul, Alexander S. Clanachan, Margaret M. Schweri, Kenner C. Rice, William L. West, Victoria Moncada, Mohamed A. Bayorh, Myrtle Thierry-Palmer and James R. Hammond and has published in prestigious journals such as FEBS Letters, Journal of Neurochemistry and Cellular and Molecular Life Sciences.

In The Last Decade

Evan F. Williams

23 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evan F. Williams United States 11 132 129 73 50 39 23 342
R.A. Podevin France 15 166 1.3× 392 3.0× 37 0.5× 28 0.6× 28 0.7× 23 608
Nobuko Matsumura Japan 11 97 0.7× 171 1.3× 45 0.6× 24 0.5× 13 0.3× 18 436
Yolanda Gutiérrez‐Martín Spain 12 76 0.6× 198 1.5× 102 1.4× 21 0.4× 15 0.4× 15 525
U. Borchard Germany 15 160 1.2× 349 2.7× 38 0.5× 25 0.5× 16 0.4× 56 723
K. McKechnie United Kingdom 12 94 0.7× 242 1.9× 292 4.0× 29 0.6× 29 0.7× 17 652
Ravi B. Marala United States 13 176 1.3× 476 3.7× 57 0.8× 31 0.6× 107 2.7× 17 790
Mark Holck Switzerland 13 219 1.7× 379 2.9× 44 0.6× 9 0.2× 49 1.3× 20 571
Mary Keen United Kingdom 16 179 1.4× 321 2.5× 44 0.6× 7 0.1× 21 0.5× 38 503
M. Grohmann Germany 14 147 1.1× 258 2.0× 48 0.7× 21 0.4× 5 0.1× 23 549
Maggie S. McIntyre United States 9 73 0.6× 272 2.1× 57 0.8× 15 0.3× 27 0.7× 9 464

Countries citing papers authored by Evan F. Williams

Since Specialization
Citations

This map shows the geographic impact of Evan F. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan F. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan F. Williams more than expected).

Fields of papers citing papers by Evan F. Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan F. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan F. Williams. The network helps show where Evan F. Williams may publish in the future.

Co-authorship network of co-authors of Evan F. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Evan F. Williams. A scholar is included among the top collaborators of Evan F. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan F. Williams. Evan F. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bayorh, Mohamed A., Evan F. Williams, Myrtle Thierry-Palmer, et al.. (1999). Enhanced Nitric Oxide Synthesis Reverses Salt-Induced Alterations in Blood Flow and Cgmp Levels. Clinical and Experimental Hypertension. 21(4). 333–352. 4 indexed citations
2.
Bayorh, Mohamed A., Evan F. Williams, Myrtle Thierry-Palmer, et al.. (1998). Possible Mechanisms of Salt-Induced Hypertension in Dahl Salt-Sensitive Rats. Physiology & Behavior. 65(3). 563–568. 20 indexed citations
3.
Thierry-Palmer, Myrtle, et al.. (1998). Exogenous 25-hydroxycholecalciferol does not attenuate salt-induced hypertension. The Journal of Steroid Biochemistry and Molecular Biology. 67(3). 193–199. 8 indexed citations
4.
Thierry-Palmer, Myrtle, Mohamed A. Bayorh, Nerimiah Emmett, et al.. (1998). Plasma 25-hydroxyvitamin D concentrations are inversely associated with blood pressure of Dahl salt-sensitive rats. The Journal of Steroid Biochemistry and Molecular Biology. 66(4). 255–261. 22 indexed citations
5.
Williams, Evan F., et al.. (1996). Comparison of Nucleoside Transport Binding Sites in Rabbit Iris-Ciliary Body and Cultured Rabbit Nonpigmented Ciliary Epithelial Cells. Journal of Ocular Pharmacology and Therapeutics. 12(4). 461–469. 4 indexed citations
6.
7.
Bayorh, Mohamed A., et al.. (1996). Effects of MaxEpa on Salt-Induced Hypertension: Relationship to [3H]Nitrobenzylthioinosine Binding Sites. Clinical and Experimental Hypertension. 18(1). 37–49. 8 indexed citations
8.
Williams, Evan F., Ifeoma Maureen Ezeonu, & Kamla Dutt. (1994). Nucleoside transport sites in a cultured human retinal cell line established by SV-40 T antigen gene. Current Eye Research. 13(2). 109–118. 12 indexed citations
9.
10.
11.
Williams, Evan F., et al.. (1990). Changes in renal, platelet and cardiac nitrobenzylthioinosine binding in spontaneously hypertensive rats. Life Sciences. 46(14). 1007–1012. 5 indexed citations
12.
Hammond, James R., Evan F. Williams, & Alexander S. Clanachan. (1985). Affinity of calcium channel inhibitors, benzodiazepines, and other vasoactive compounds for the nucleoside transport system. Canadian Journal of Physiology and Pharmacology. 63(10). 1302–1307. 18 indexed citations
13.
Williams, Evan F., et al.. (1984). Nucleoside transport in heart: species differences in nitrobenzylthioinosine binding, adenosine accumulation, and drug-induced potentiation of adenosine action. Canadian Journal of Physiology and Pharmacology. 62(1). 31–37. 47 indexed citations
14.
Williams, Evan F. & Alexander S. Clanachan. (1983). Saturable, high affinity binding of the nucleoside transport inhibitor, nitrobenzylthioinosine, to guinea pig cardiac membranes. European Journal of Pharmacology. 87(1). 133–136. 6 indexed citations
15.
Skolnick, Phil, Evan F. Williams, J. M. Cook, et al.. (1982). beta-Carbolines and benzodiazepine receptors: structure-activity relationships and pharmacologic activity.. PubMed. 90. 233–52. 8 indexed citations
16.
Skolnick, Phil, Margaret M. Schweri, Eberhard Kutter, Evan F. Williams, & Steven M. Paul. (1982). Inhibition of [3H]Diazepam and [3H]3‐Carboethoxy‐β‐Carboline Binding by Irazepine: Evidence for Multiple “Domains” of the Benzodiazepine Receptor. Journal of Neurochemistry. 39(4). 1142–1146. 25 indexed citations
17.
Watanabe, Kouichi, et al.. (1981). Effects of vinca alkaloids on calcium-calmodulin regulated cyclic adenosine 3',5'-monophosphate phosphodiesterase activity from brain. Biochemical Pharmacology. 30(4). 335–340. 21 indexed citations
18.
Williams, Evan F., Steven M. Paul, Kenner C. Rice, Michael Cain, & Phil Skolnick. (1981). Binding of [3H]ethyl‐β‐carboline‐3‐carboxylate to brain benzodiazepine receptors. FEBS Letters. 132(2). 269–272. 15 indexed citations
19.
Williams, Evan F., Kenner C. Rice, Steven M. Paul, & Phil Skolnick. (1980). Heterogeneity of Benzodiazepine Receptors in the Central Nervous System Demonstrated with Kenazepine, an Alkylating Benzodiazepine. Journal of Neurochemistry. 35(3). 591–597. 40 indexed citations
20.
Watanabe, Kentaro, et al.. (1979). Specific inhibition of a calcium dependent activation of brain cyclic AMP phosphodiesterase activity by vinblastine. Cellular and Molecular Life Sciences. 35(11). 1487–1489. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R.A. Podevin Breakdown of academic impact, for papers by Nobuko Matsumura Breakdown of academic impact, for papers by Yolanda Gutiérrez‐Martín Breakdown of academic impact, for papers by U. Borchard Breakdown of academic impact, for papers by K. McKechnie Breakdown of academic impact, for papers by Ravi B. Marala Breakdown of academic impact, for papers by Mark Holck Breakdown of academic impact, for papers by Mary Keen Breakdown of academic impact, for papers by M. Grohmann Breakdown of academic impact, for papers by Maggie S. McIntyre
Rankless by CCL
2026